Back to Journals » OncoTargets and Therapy » Volume 13

GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin

Total article views   HTML views PDF downloads Totals
4,930 Dovepress* 4,526+ 772 5,298
PubMed Central* 404 102 506
Totals 4,930 874 5,804
*Since 30 June 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed and Google Scholar